98 related articles for article (PubMed ID: 26752566)
1. Ethical Issues in Interpretation of Risk, from the Perspective of a Research Subject.
Davis D
Narrat Inq Bioeth; 2015; 5(3):203-6. PubMed ID: 26752566
[No Abstract] [Full Text] [Related]
2. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
Abyad A; al Imad R
J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
[No Abstract] [Full Text] [Related]
3. Alzheimer's tests under fire.
Hayden EC
Nature; 2008 Oct; 455(7217):1155. PubMed ID: 18971983
[No Abstract] [Full Text] [Related]
4. Genetic Risk of Alzheimer's Disease - Sleepless with the Enemy.
Noyce AJ; Klein C
Ann Neurol; 2021 Jan; 89(1):27-29. PubMed ID: 33070350
[No Abstract] [Full Text] [Related]
5. Return of results: not that complicated?
Evans JP; Rothschild BB
Genet Med; 2012 Apr; 14(4):358-60. PubMed ID: 22481183
[No Abstract] [Full Text] [Related]
6. Alzheimer's (AD).
J Pract Nurs; 2009; 59(2):5-7. PubMed ID: 19718998
[No Abstract] [Full Text] [Related]
7. Special issues in genetic testing for Alzheimer disease.
Greely HT
Genet Test; 1999; 3(1):115-9. PubMed ID: 10464585
[TBL] [Abstract][Full Text] [Related]
8. Effect of genetic testing for risk of Alzheimer's disease.
Kane RA; Kane RL
N Engl J Med; 2009 Jul; 361(3):298-9. PubMed ID: 19605835
[No Abstract] [Full Text] [Related]
9. Genetic testing and Alzheimer disease: ethical issues for providers and families.
Cassel CK
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 3():S16-20. PubMed ID: 9876938
[No Abstract] [Full Text] [Related]
10. Informed consent for genetic research involving pleiotropic genes: an empirical study of ApoE research.
Cooper ZN; Nelson RM; Ross LF
IRB; 2006; 28(5):1-11. PubMed ID: 17152129
[No Abstract] [Full Text] [Related]
11. Diagnostic testing in neurogenetics. Principles, limitations, and ethical considerations.
Paulson HL
Neurol Clin; 2002 Aug; 20(3):627-43, v. PubMed ID: 12432824
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and genetic testing.
Karlinsky H; Lennox A; Rossor M
Alzheimer Dis Assoc Disord; 1994; 8(2):63-5; discussion 66-7. PubMed ID: 8060607
[No Abstract] [Full Text] [Related]
13. Postgenomics, uncertain futures, and the familiarization of susceptibility genes.
Chilibeck G; Lock M; Sehdev M
Soc Sci Med; 2011 Jun; 72(11):1768-75. PubMed ID: 20570031
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing and Alzheimer's disease.
Health News; 1998 Mar; 4(4):5. PubMed ID: 9553608
[No Abstract] [Full Text] [Related]
15. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
Borroni B; Di Luca M; Padovani A
Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
[No Abstract] [Full Text] [Related]
16. The benefits of apolipoprotein E epsilon4 screening to research.
Gauthier S
CMAJ; 2004 Oct; 171(8):881. PubMed ID: 15477627
[No Abstract] [Full Text] [Related]
17. Ethical issues in genetics and aging: diagnosis, treatment, and prevention in the era of molecular medicine.
McCullough LB; Wilson NL; Rhymes JA; Teasdale TA
Generations; 2000; 24(1):72-8. PubMed ID: 17333579
[No Abstract] [Full Text] [Related]
18. Genetics and molecular biology.
Cattin L; Baralle FE
Curr Opin Lipidol; 1997 Feb; 8(1):U4-5. PubMed ID: 9127715
[No Abstract] [Full Text] [Related]
19. Offering unproven genetic tests to the public is irresponsible.
Oliveira JR
Nature; 2008 Dec; 456(7222):570. PubMed ID: 19052602
[No Abstract] [Full Text] [Related]
20. Using genomic data to make indirect (and unauthorized) estimates of disease risk.
Nyholt DR
Public Health Genomics; 2012; 15(5):303-11. PubMed ID: 22722694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
